EC Number |
Inhibitors |
Structure |
---|
2.4.2.29 | more |
design, synthesis, and in vitro evaluation of novel tricyclic TGT inhibitors based on the lin-benzoguanine scaffold |
|
2.4.2.29 | 2,3-Dihydroxybenzoic acid |
- |
|
2.4.2.29 | 2-amino-5-(fluoromethyl)pyrrolo[2,3-d]pyrimidin-4(3H)-one |
inactivation and competitive inhibition. 2-amino-5-(fluoromethyl)pyrrolo[2,3-d]pyrimidin-4(3H)-one appears to partition between: 1. normal turnover, 2. inactivation, 3. an alternative processing to an unidentrified fluoride-released product |
|
2.4.2.29 | 6-aminoimidazol[4,5-g]quinazolin-8(7H)-one |
- |
|
2.4.2.29 | 6-aminoimidazol[4,5-g]quinazolin-8(7H)-one |
mixed competitive-uncompetitive inhibition with respect to tRNA binding |
|
2.4.2.29 | 4-aminophthalhydrazide |
- |
|
2.4.2.29 | 2,6-diaminoquinazolin-4(3H)-one |
- |
|
2.4.2.29 | 2-aminoquinazolin-4(3H)-one |
- |
|
2.4.2.29 | 2-amino-8-methylquinazolin-4(3H)-one |
- |
|
2.4.2.29 | 6-amino-4-phenyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one |
- |
|